U.S. Cardiac Catheters & Guidewires Market Revenue & Forecast Analysis, 2026-2035
The U.S. cardiac catheters and guidewires market was evaluated at USD 6.20 billion in 2025 and is projected to grow at a CAGR of 6.6% from USD 6.51 billion in 2026 to USD 11.60 billion in 2035. The robust market expansion is primarily driven by the rising prevalence of cardiovascular diseases, including coronary artery disease, heart failure, arrhythmias, and congenital heart disorders, which are increasing the demand for diagnostic and interventional cardiovascular procedures. Additionally, the growing geriatric population and rising preference for minimally invasive cardiac interventions are driving the adoption of cardiac catheters and guidewires, supporting market growth.
Market Overview
The U.S. cardiac catheters and guidewires market is projected to experience significant growth throughout the forecast period due to the increasing adoption of robotic-assisted cardiovascular procedures, growing demand for outpatient cardiac interventions, and expanding investments in cardiac care infrastructure. Advancements in catheter and guidewire technologies are expected to support market expansion. By 2035, hospitals and cardiac centers across the U.S. are expected to increase their use of advanced cardiac catheters and guidewires to improve procedural efficiency and patient outcomes.
The U.S. cardiac catheters and guidewires market has expanded consistently over time, driven by increasing healthcare expenditure, the expansion of cardiac catheterisation laboratories, and continuous advancements in catheter and guidewire technologies. Innovations in electrophysiology, angiography, and ablation catheters, along with improved guidewire design and navigation capabilities, have enhanced procedural precision and patient outcomes. For instance, in January 2024, Boston Scientific received U.S. FDA approval for the FARAPULSE Pulsed Field Ablation System, expanding its electrophysiology product portfolio.
U.S. Cardiac Catheters and Guidewires Market Overview
Base Year Market Size (2025): USD 6.20 billion
CAGR: 6.6%
Forecast Year Market Size (2035): USD 11.60 billion
Major Players:
Abbott
Boston Scientific Corporation
Medtronic plc
Biosense Webster (Johnson & Johnson)
Terumo Medical Corporation
U.S. Cardiac Catheters and Guidewires Market Trends
The U.S. cardiac catheters and guidewires market is evolving rapidly due to technological innovation in cardiovascular interventions, increasing procedural efficiency requirements, and the growing focus on precision-based cardiac care.
The increasing adoption of robotic-assisted catheter navigation systems is enhancing procedural accuracy and reducing physician radiation exposure during complex interventions.
The growing use of sensor-enabled and mapping catheters is improving real-time cardiac visualisation and supporting more precise electrophysiology procedures.
The rising demand for advanced guidewires with enhanced steerability, flexibility, and torque control is improving navigation through complex vascular anatomies and supporting procedural success.
The expansion of outpatient catheterisation laboratories and ambulatory surgical centers is increasing the utilisation of streamlined catheter and guidewire solutions designed for same-day procedures.
Collectively, these trends are expected to support the continued growth of the U.S. cardiac catheters and guidewires market by enhancing procedural precision, operational efficiency, and patient care quality.
U.S. Cardiac Catheters and Guidewires Market Analysis
By Product Type
Cardiac catheters dominate the U.S. cardiac catheters and guidewires market due to their broad clinical applications
Based on the product type, the U.S. cardiac catheters and guidewires market is categorised into cardiac catheters and cardiac guidewires. The cardiac catheters segment leads the market with the highest market share in 2025.
By End-use
Hospitals dominate the U.S. cardiac catheters and guidewires market due to high procedure volumes
Based on the end-use, the U.S. cardiac catheters and guidewires market is categorised into hospitals, cardiology centers, and others. The hospitals segment leads the market with the highest market share in 2025.
Key Companies Profiled
The U.S. cardiac catheters and guidewires market features a competitive landscape with leading cardiovascular device manufacturers competing through innovative catheter and guidewire technologies. Key players such as Abbott, Boston Scientific Corporation, Medtronic plc, Biosense Webster (Johnson & Johnson), and Terumo Medical Corporation hold a significant share of the market, supported by extensive product portfolios, strong clinical expertise, and established distribution networks.
The market is highly competitive, with companies focusing on electrophysiology catheters, angiography catheters, ablation catheters, and advanced guidewires to strengthen their market positions. The increasing demand for minimally invasive cardiovascular procedures and continuous technological advancements are further intensifying competition. For instance, in 2024, Boston Scientific received U.S. FDA approval for the FARAWAVE NAV Ablation Catheter, reinforcing competition in the cardiac electrophysiology segment.
U.S. Cardiac Catheters and Guidewires Market Companies:
Some of the key companies operating in the U.S. Cardiac Catheters and Guidewires Market include:
• Abbott
• Asahi Intecc USA, Inc.
• BD (Becton, Dickinson and Company)
• Biosense Webster (Johnson & Johnson)
• Boston Scientific Corporation
• Cardinal Health, Inc.
• Cook Medical
• Cordis
• Integer Holdings Corporation
• Medtronic plc
• Merit Medical Systems, Inc.
• Penumbra, Inc.
• Stryker Corporation
• Teleflex Incorporated
• Terumo Medical Corporation
Market Segmentation
This study provides revenue growth and emerging trends across the U.S. levels from 2021 to 2035, segmenting the U.S. cardiac catheters and guidewires market by-
Product Type (Revenue in USD Million, 2021 - 2035)
Cardiac Catheters
Electrophysiology Catheters
PTCA Balloon Catheters
IVUS Catheters
PTA balloon Catheters
Guide Extension Catheters
Others
Cardiac Guidewires
End-use (Revenue in USD Million, 2021 – 2035)
Hospitals
Cardiology Centers
Others
Table of Content
1. Methodology and Scope
1.1. Scope of the Study
1.1.1. Market Segmentation
1.1.2. Market Definition
1.1.3. Inclusions and Exclusions of the Study
1.2. Research Design
1.2.1. Base Year, Historical Data, and Forecast Period
1.2.2. Data Collection Methods
1.2.2.1. Secondary Sources
1.2.2.2. Primary Sources
1.2.3. Research Methodology
1.2.3.1. Base Year Calculation/ Parent Market Analysis, Company/ Brand Share Analysis, 2025 (Top-down Approach)
1.2.3.2. Volume-Price Approach (Bottom-up Approach)
1.2.3.3. Data Triangulation
1.2.4. Forecasting Model
1.3. Research Assumptions
1.4. Validation and Data Quality Control
1.5. List of Primary Sources
1.6. List of Secondary Sources
2. Executive Summary
2.1. Market Overview
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
3. Industry Outlook
3.1. Industry Ecosystem Analysis
3.2. Parent/ Ancillary Market Analysis
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Restraints/ Challenges
3.3.3. Opportunities
3.4. Consumer Behaviour Analysis
3.5. Value Chain Analysis
3.6. Technology Roadmap
3.7. Porters Analysis
3.8. PESTLE Analysis
4. Market Estimates and Forecasts, By Product Type, 2021 - 2035 (Market Size in USD Mn)
4.1. Cardiac Catheters
4.1.1. Electrophysiology Catheters
4.1.2. PTCA Balloon Catheters
4.1.3. IVUS Catheters
4.1.4. PTA balloon Catheters
4.1.5. Guide Extension Catheters
4.1.6. Others
4.2. Cardiac Guidewires
5. Market Estimates and Forecasts, By End-use, 2021 – 2035 (USD Mn)
5.1. Hospitals
5.2. Cardiology Centers
5.3. Others
6. Market Estimates and Forecasts, By U.S., 2021 - 2035 (USD Mn)
6.1.1. U.S.
6.1.1.1. U.S. Cardiac Catheters and Guidewires Market Estimates and Forecasts to 2035 (USD Mn)
6.1.1.2. Market Dynamics
6.1.1.3. Competitive Landscape
6.1.1.4. Regulatory Framework
6.1.1.5. Reimbursement Scenario
7. Competitive Landscape
7.1. Company Market Share Analysis, 2025
7.2. Company Tier Structure
7.3. List of Major Suppliers, By Key Countries
7.4. Key Company Positioning Analysis
7.5. Company Profile
7.5.1. Abbott
7.5.2. Asahi Intecc USA, Inc.
7.5.3. BD (Becton, Dickinson and Company)
7.5.4. Biosense Webster (Johnson & Johnson)
7.5.5. Boston Scientific Corporation
7.5.6. Cardinal Health, Inc.
7.5.7. Cook Medical
7.5.8. Cordis
7.5.9. Integer Holdings Corporation
7.5.10. Medtronic plc
7.5.11. Merit Medical Systems, Inc.
7.5.12. Penumbra, Inc.
7.5.13. Stryker Corporation
7.5.14. Teleflex Incorporated
7.5.15. Terumo Medical Corporation
8. Analyst Perspective
9. Related Reports
Related Research
Revolution Insights Briefs
Stay informed with updates on related market reports and key industry topics.